Information  X 
Enter a valid email address

Worldwide Healthcare (WWH)


Wednesday 21 July, 2021

Worldwide Healthcare

Edison issues review on Worldwide Healthcare Trust

RNS Number : 8525F
Worldwide Healthcare Trust PLC
21 July 2021


London, UK, 21 July 2021


Edison issues review on Worldwide Healthcare Trust (WWH)

Worldwide Healthcare Trust (WWH) has two very experienced co-managers, Sven Borho and Trevor Polischuk at healthcare specialist investor OrbiMed. They remain very positive on the outlook for the healthcare sector due to favourable industry fundamentals and relatively attractive valuations. Despite a period of underperformance this year due to the outperformance of large-cap companies and a market rotation from growth to value stocks given increased confidence in a post-pandemic economic rebound, WWH retains a long-term record of outperformance versus the MSCI World Health Care index. In FY21 the trust posted its fourth-best year of excess return versus its benchmark in its 26-year history; this was primarily due to successful stock selection in both listed and unquoted companies.


The trust's shares are trading at a 0.1% discount to cum-income NAV, which compares to a range of an average 0.7% premium to a 0.3% discount over the last one, three and five years. Shares are issued regularly to manage the premium; in FY21, WWH's share base increased by a significant c 20%, which raised £380.6m. 

Click here to view the full report or here to sign up to receive research as it is published.


All reports published by Edison are available to download free of charge from its website

About Edison: E dison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority .

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 [email protected]

Sarah Godfrey +44 (0)20 3681 2519 [email protected]

Learn more at and connect with Edison on: 




This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t